Joel Ackerman - 19 Oct 2022 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Reporting relationship: Director
Issuer ticker: CSBR
Reported as of: 19 Oct 2022
Net transaction value: +$53,501
SEC form: 4
Accepted by SEC: 20 Oct 2022, 13:26:54 UTC
Prior SEC filing: 17 May 2022
Next SEC filing: 17 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Joel Ackerman

Key filing fact

Joel Ackerman filed Form 4 for CHAMPIONS ONCOLOGY, INC. (CSBR) on 20 Oct 2022.

Key facts

This page summarizes Joel Ackerman's Form 4 filing for CHAMPIONS ONCOLOGY, INC. (CSBR).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Oct 2022, 13:26.

Change

Previous filing in this sequence was filed on 17 May 2022.
Current net transaction value: +$53,501.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSBR transaction

Common Stock

Options Exercise

Transaction value: $53,501
Shares: +16,667
Change %: +1.2%
Price: $3.21
Shares after: 1,460,595
Date: 19 Oct 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSBR transaction Derivative

Option to purchase Common Stock

Options Exercise

Transaction value: $0
Shares: +16,667
Change %
Price: $0.000000^*
Shares after: 0
Date: 19 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,667
Exercise price: $3.21
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018, respectively.